# Comvee

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/comvee

- Industry: Healthcare IT
- Headquarters: Fuzhou, China
- Website: www.comvee.cn
- Total disclosed funding: $9.8M
- Latest round: Series B (Apr 18, 2017)
- Investors on record: 5

## About

Comvee is a technology firm specializing in digital solutions for disease management, catering primarily to hospitals and pharmaceutical companies. The company offers innovative platforms aimed at enhancing patient care and operational efficiency.Founded in 2002, Comvee operates out of Fuzhou, China, providing digital health solutions. The company has raised a total of CNY 60.00 mn through its Series A funding round, with notable investors including GX Capital, Jifeng Ventures, and Shangshi Fund. The founder, Xingxin Guo, has a history of involvement in healthcare technology.???????????? specializes in providing digital solutions for disease management, primarily targeting hospitals and pharmaceutical companies. Its core offerings include comprehensive disease management platforms that facilitate the integration of clinical workflows, streamline standardization in patient care, and support real-world research. The company's flagship products encompass a diabetes management system, a tumor management system for county-level hospitals, and chronic disease management solutions, all designed to enhance clinical effectiveness and academic reputation. These products are utilized in diverse healthcare settings, including outpatient departments, inpatient facilities, and home care environments, aiming to optimize patient outcomes and operational efficiency across various regions. The company's client base comprises over 1,500 hospitals, and its solutions are marketed not only within China but also in international markets, reflecting a commitment to expanding its impact globally.The revenue model of ???????????? is primarily structured around B2B transactions, focusing on subscription services and partnerships. The company engages in direct sales with healthcare institutions, providing tailored disease management systems and ongoing support for research initiatives. Transactions often involve multi-year contracts, enabling hospitals to integrate advanced disease management capabilities. Additionally, the company collaborates with pharmaceutical firms to offer specialized clinical research services, diversifying its revenue streams. Pricing structures for services are customized based on client needs, ensuring healthcare facilities receive targeted support.Comvee aims to expand its product offerings with upcoming enhancements to its disease management platforms slated for launch in 2024. The company plans to enter new markets in Southeast Asia and Europe by the end of 2025, leveraging recent Series A funding of CNY 60.00 mn to support these initiatives. This funding will facilitate product development and marketing efforts in the targeted regions, allowing Comvee to broaden its reach and impact in the healthcare technology sector.

## Funding rounds

- Series B, Apr 18, 2017 — Fujian Venture, LYFE Capital
- Series A, Jun 1, 2015, $9.8M — GX Capital, Shangshi Fund, Jifeng Ventures

## Investors

- GX Capital (https://capitalatlas.ai/funds/gx-capital) — Series A
- Shangshi Fund (https://capitalatlas.ai/funds/shangshi-fund) — Series A
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Series A
- Fujian Venture (https://capitalatlas.ai/funds/fujian-venture) — Series B
- LYFE Capital — Series B